The bacteriostatic agent (typically 0.9% benzyl alcohol) prevents bacterial growth, extending the usable life of your reconstituted peptide
Semaglutide (Wegovy and Ozempic) is an FDA-approved GLP-1 agonist for type 2 diabetes and weight management, which works by suppressing appetite, slowing gastric emptying, increasing feelings of fullness, and reducing calorie intake
Some participants achieved weight loss of approximately 24% of body weight at 48 weeks approaching levels reported with some bariatric surgical procedures, though no direct head-to-head comparisons have been conducted and long-term durability beyond the trial period remains unknown
Key active ingredients include L-Glutathione
And theres another population Crosby is especially interested in: women with ductal carcinoma in situ (DCIS), a non-invasive condition that can progress to breast cancer
Adult -cells are not thought to produce much GLP-1, and a release of GLP-1 is barely detectable from the perfused pancreas of normal mice (111)
